Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral Antipsychotics
The Journal of Clinical Psychiatry · 2025
DOI: 10.4088/jcp.25m16033 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Clinical Psychiatry, 2025. Verfasst von Farah Khorassani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy Practice, University of California, Irvine School of Pharmacy and Pharmaceutical Sciences, Irvine, California. Hauptthemen laut MEDLINE: Antipsychotic Agents, Pregnancy Complications, Pregnancy Outcome.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy Practice, University of California, Irvine School of Pharmacy and Pharmaceutical Sciences, Irvine, California.
- Department of Psychiatry and Human Behavior, University of California, Irvine School of Medicine, Orange, California.
- University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California.
- Corresponding Author: Kelly C. Lee, PharmD, Department of Pharmacy Practice and Sciences, University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Dr, MC 0657, La Jolla, CA…
Zitieren
APA
Khorassani, F., Espejo, G., & Lee, K. C. (2025). Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral Antipsychotics. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.25m16033
Vancouver
Khorassani F, Espejo G, Lee KC. Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral Antipsychotics. The Journal of Clinical Psychiatry. 2025. doi:10.4088/jcp.25m16033
BibTeX
@article{Khorassani2025,
author = {Khorassani, Farah and Espejo, Gemma and Lee, Kelly C},
title = {Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral Antipsychotics},
journal = {The Journal of Clinical Psychiatry},
year = {2025},
doi = {10.4088/jcp.25m16033}
}
EUVIMED